Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
Issued Date
2024-01-01
Resource Type
ISSN
14733099
eISSN
14744457
Scopus ID
2-s2.0-85184766931
Journal Title
The Lancet Infectious Diseases
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Infectious Diseases (2024)
Suggested Citation
Chang C.C., Harrison T.S., Bicanic T.A., Chayakulkeeree M., Sorrell T.C., Warris A., Hagen F., Spec A., Oladele R., Govender N.P., Chen S.C., Mody C.H., Groll A.H., Chen Y.C., Lionakis M.S., Alanio A., Castañeda E., Lizarazo J., Vidal J.E., Takazono T., Hoenigl M., Alffenaar J.W., Gangneux J.P., Soman R., Zhu L.P., Bonifaz A., Jarvis J.N., Day J.N., Klimko N., Salmanton-García J., Jouvion G., Meya D.B., Lawrence D., Rahn S., Bongomin F., McMullan B.J., Sprute R., Nyazika T.K., Beardsley J., Carlesse F., Heath C.H., Ayanlowo O.O., Mashedi O.M., Queiroz-Telles Filho F., Hosseinipour M.C., Patel A.K., Temfack E., Singh N., Cornely O.A., Boulware D.R., Lortholary O., Pappas P.G., Perfect J.R. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. The Lancet Infectious Diseases (2024). doi:10.1016/S1473-3099(23)00731-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/97265
Title
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
Author(s)
Chang C.C.
Harrison T.S.
Bicanic T.A.
Chayakulkeeree M.
Sorrell T.C.
Warris A.
Hagen F.
Spec A.
Oladele R.
Govender N.P.
Chen S.C.
Mody C.H.
Groll A.H.
Chen Y.C.
Lionakis M.S.
Alanio A.
Castañeda E.
Lizarazo J.
Vidal J.E.
Takazono T.
Hoenigl M.
Alffenaar J.W.
Gangneux J.P.
Soman R.
Zhu L.P.
Bonifaz A.
Jarvis J.N.
Day J.N.
Klimko N.
Salmanton-García J.
Jouvion G.
Meya D.B.
Lawrence D.
Rahn S.
Bongomin F.
McMullan B.J.
Sprute R.
Nyazika T.K.
Beardsley J.
Carlesse F.
Heath C.H.
Ayanlowo O.O.
Mashedi O.M.
Queiroz-Telles Filho F.
Hosseinipour M.C.
Patel A.K.
Temfack E.
Singh N.
Cornely O.A.
Boulware D.R.
Lortholary O.
Pappas P.G.
Perfect J.R.
Harrison T.S.
Bicanic T.A.
Chayakulkeeree M.
Sorrell T.C.
Warris A.
Hagen F.
Spec A.
Oladele R.
Govender N.P.
Chen S.C.
Mody C.H.
Groll A.H.
Chen Y.C.
Lionakis M.S.
Alanio A.
Castañeda E.
Lizarazo J.
Vidal J.E.
Takazono T.
Hoenigl M.
Alffenaar J.W.
Gangneux J.P.
Soman R.
Zhu L.P.
Bonifaz A.
Jarvis J.N.
Day J.N.
Klimko N.
Salmanton-García J.
Jouvion G.
Meya D.B.
Lawrence D.
Rahn S.
Bongomin F.
McMullan B.J.
Sprute R.
Nyazika T.K.
Beardsley J.
Carlesse F.
Heath C.H.
Ayanlowo O.O.
Mashedi O.M.
Queiroz-Telles Filho F.
Hosseinipour M.C.
Patel A.K.
Temfack E.
Singh N.
Cornely O.A.
Boulware D.R.
Lortholary O.
Pappas P.G.
Perfect J.R.
Author's Affiliation
Medizinische Fakultät
Lagos University Teaching Hospital
Siriraj Hospital
UWA Medical School
Fiona Stanley Hospital
Graduate School of Biomedical Sciences
Université Paris Cité
Dynamyc (EA 7380)
Gulu University
Duke University Medical Center
BioTechMed-Graz
Botswana Harvard AIDS Institute Partnership
Institut de Recherche en Santé, Environnement et Travail
Centre for the AIDS Programme of Research in South Africa
Deenanath Mangeshkar Hospital and Research Center, Pune
National Taiwan University Hospital
UNC Project-Malawi
School of Medicine, Makerere University College of Health Sciences
Kenya Medical Research Institute
Instituto de Infectologia Emilio Ribas
Instituto Nacional de Salud
University Medical Center Utrecht
St George's University Hospitals NHS Foundation Trust
Universidad Nacional Autónoma de México
London School of Hygiene & Tropical Medicine
University of Minnesota Twin Cities
St George’s, University of London
UAB Division of Infectious Disease
Centre Hospitalier Universitaire de Rennes
Institute for Biodiversity and Ecosystem Dynamics - Amsterdam
UNSW Sydney
University of Exeter
The University of Sydney
College of Medicine, University of Lagos
Washington University School of Medicine in St. Louis
P.D. Hinduja National Hospital and Medical Research Centre
Nagasaki University Hospital
Centers for Disease Control and Prevention
Liverpool School of Tropical Medicine
UNC School of Medicine
Great Ormond Street Hospital for Children NHS Foundation Trust
National Institute of Allergy and Infectious Diseases (NIAID)
Sydney Children's Hospital, Randwick
School of Pathology
Universidade Federal do Parana
Universidade Federal de São Paulo
Royal Devon and Exeter Hospital
Faculty of Medicine, Nursing and Health Sciences
Faculty of Health Sciences
Faculty of Medicine and Health
National Health Research Institutes Taiwan
Fudan University
Uniklinik Köln
Ecole Nationale Vétérinaire d'Alfort
Universidade de São Paulo
The Alfred
Universitätsklinikum Münster
Medizinische Universität Graz
Westmead Hospital
Institut Pasteur, Paris
Westerdijk Fungal Biodiversity Institute - KNAW
University of Pittsburgh School of Medicine
Cumming School of Medicine
I Mechnikov North Western State Medical University
Institute of Clinical Pathology and Medical Research
Partner Site Bonn-Cologne
Jupiter Hospital
Univesidad de Pamplona
Sterling Hospital
Lagos University Teaching Hospital
Siriraj Hospital
UWA Medical School
Fiona Stanley Hospital
Graduate School of Biomedical Sciences
Université Paris Cité
Dynamyc (EA 7380)
Gulu University
Duke University Medical Center
BioTechMed-Graz
Botswana Harvard AIDS Institute Partnership
Institut de Recherche en Santé, Environnement et Travail
Centre for the AIDS Programme of Research in South Africa
Deenanath Mangeshkar Hospital and Research Center, Pune
National Taiwan University Hospital
UNC Project-Malawi
School of Medicine, Makerere University College of Health Sciences
Kenya Medical Research Institute
Instituto de Infectologia Emilio Ribas
Instituto Nacional de Salud
University Medical Center Utrecht
St George's University Hospitals NHS Foundation Trust
Universidad Nacional Autónoma de México
London School of Hygiene & Tropical Medicine
University of Minnesota Twin Cities
St George’s, University of London
UAB Division of Infectious Disease
Centre Hospitalier Universitaire de Rennes
Institute for Biodiversity and Ecosystem Dynamics - Amsterdam
UNSW Sydney
University of Exeter
The University of Sydney
College of Medicine, University of Lagos
Washington University School of Medicine in St. Louis
P.D. Hinduja National Hospital and Medical Research Centre
Nagasaki University Hospital
Centers for Disease Control and Prevention
Liverpool School of Tropical Medicine
UNC School of Medicine
Great Ormond Street Hospital for Children NHS Foundation Trust
National Institute of Allergy and Infectious Diseases (NIAID)
Sydney Children's Hospital, Randwick
School of Pathology
Universidade Federal do Parana
Universidade Federal de São Paulo
Royal Devon and Exeter Hospital
Faculty of Medicine, Nursing and Health Sciences
Faculty of Health Sciences
Faculty of Medicine and Health
National Health Research Institutes Taiwan
Fudan University
Uniklinik Köln
Ecole Nationale Vétérinaire d'Alfort
Universidade de São Paulo
The Alfred
Universitätsklinikum Münster
Medizinische Universität Graz
Westmead Hospital
Institut Pasteur, Paris
Westerdijk Fungal Biodiversity Institute - KNAW
University of Pittsburgh School of Medicine
Cumming School of Medicine
I Mechnikov North Western State Medical University
Institute of Clinical Pathology and Medical Research
Partner Site Bonn-Cologne
Jupiter Hospital
Univesidad de Pamplona
Sterling Hospital
Corresponding Author(s)
Other Contributor(s)
Abstract
Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical cryptococcosis syndromes, the different patient types at-risk and affected, and the vastly disparate resource settings where clinicians practice pose a complex array of challenges. Expert contributors from diverse regions of the world have collated data, reviewed the evidence, and provided insightful guideline recommendations for health practitioners across the globe. This guideline offers updated practical guidance and implementable recommendations on the clinical approaches, screening, diagnosis, management, and follow-up care of a patient with cryptococcosis and serves as a comprehensive synthesis of current evidence on cryptococcosis. This Review seeks to facilitate optimal clinical decision making on cryptococcosis and addresses the myriad of clinical complications by incorporating data from historical and contemporary clinical trials. This guideline is grounded on a set of core management principles, while acknowledging the practical challenges of antifungal access and resource limitations faced by many clinicians and patients. More than 70 societies internationally have endorsed the content, structure, evidence, recommendation, and pragmatic wisdom of this global cryptococcosis guideline to inform clinicians about the past, present, and future of care for a patient with cryptococcosis.